Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 776

1.

Assessment, mechanisms, and clinical implication of variability in platelet response to aspirin and clopidogrel therapy.

Ben-Dor I, Kleiman NS, Lev E.

Am J Cardiol. 2009 Jul 15;104(2):227-33. doi: 10.1016/j.amjcard.2009.03.022. Epub 2009 May 13. Review.

PMID:
19576352
[PubMed - indexed for MEDLINE]
2.

Clopidogrel and aspirin in cardiovascular medicine: responders or not--current best available evidence.

Tourmousoglou CE, Rokkas CK.

Cardiovasc Hematol Agents Med Chem. 2008 Oct;6(4):312-22. Review.

PMID:
18855644
[PubMed - indexed for MEDLINE]
3.

Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives.

Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Alfonso F, Macaya C, Bass TA, Costa MA.

J Am Coll Cardiol. 2007 Apr 10;49(14):1505-16. Epub 2007 Mar 26. Review.

PMID:
17418288
[PubMed - indexed for MEDLINE]
Free Article
4.

Antiplatelet resistance with aspirin and clopidogrel: is it real and does it matter?

Chen WH.

Curr Cardiol Rep. 2006 Jul;8(4):301-6. Review.

PMID:
16822366
[PubMed - indexed for MEDLINE]
5.

Effect of clopidogrel treatment on stress-induced platelet activation and myocardial ischemia in aspirin-treated patients with stable coronary artery disease.

Perneby C, Wallén NH, Hofman-Bang C, Tornvall P, Ivert T, Li N, Hjemdahl P.

Thromb Haemost. 2007 Dec;98(6):1316-22.

PMID:
18064330
[PubMed - indexed for MEDLINE]
6.

Variable platelet responsiveness to aspirin and clopidogrel: role of platelet function and genetic polymorphism testing.

Azam SM, Jozic J.

Transl Res. 2009 Dec;154(6):309-13. doi: 10.1016/j.trsl.2009.09.011. Epub 2009 Oct 14. Review.

PMID:
19931197
[PubMed - indexed for MEDLINE]
7.

Platelet resistance to antiplatelet drugs.

Kumar A, Kao J.

Recent Pat Cardiovasc Drug Discov. 2009 Jun;4(2):98-108. Review.

PMID:
19519552
[PubMed - indexed for MEDLINE]
8.

Variability in platelet response to the antiplatelet agents aspirin and clopidogrel: mechanisms, measurement, and clinical relevance.

Jennings LK.

Crit Pathw Cardiol. 2009 Mar;8(1):20-8. doi: 10.1097/HPC.0b013e318194e45e. Review.

PMID:
19258834
[PubMed - indexed for MEDLINE]
9.

Comparison of increased aspirin dose versus combined aspirin plus clopidogrel therapy in patients with diabetes mellitus and coronary heart disease and impaired antiplatelet response to low-dose aspirin.

Duzenli MA, Ozdemir K, Aygul N, Soylu A, Tokac M.

Am J Cardiol. 2008 Aug 15;102(4):396-400. doi: 10.1016/j.amjcard.2008.03.074. Epub 2008 May 22.

PMID:
18678294
[PubMed - indexed for MEDLINE]
10.

Significance of aspirin and clopidogrel resistance in patients undergoing percutaneous coronary interventions.

Pregowski J, Witkowski A, Sitkiewicz D.

Curr Vasc Pharmacol. 2007 Apr;5(2):135-40. Review.

PMID:
17430218
[PubMed - indexed for MEDLINE]
11.

Variable response to clopidogrel in patients with coronary artery disease.

Geisler T, Gawaz M.

Semin Thromb Hemost. 2007 Mar;33(2):196-202. Review.

PMID:
17340469
[PubMed - indexed for MEDLINE]
12.

Resistance to antiplatelet therapy.

Guthikonda S, Lev EI, Kleiman NS.

Curr Cardiol Rep. 2005 Jul;7(4):242-8. Review.

PMID:
15987620
[PubMed - indexed for MEDLINE]
13.

Role of clopidogrel in managing atherothrombotic cardiovascular disease.

Eshaghian S, Kaul S, Amin S, Shah PK, Diamond GA.

Ann Intern Med. 2007 Mar 20;146(6):434-41. Review.

PMID:
17371888
[PubMed - indexed for MEDLINE]
14.

Aspirin and clopidogrel: a sweeping combination in cardiology.

Manolis AS, Tzeis S, Andrikopoulos G, Koulouris S, Melita H.

Curr Med Chem Cardiovasc Hematol Agents. 2005 Jul;3(3):203-19. Review.

PMID:
15974885
[PubMed - indexed for MEDLINE]
15.

Clinical implications of clopidogrel resistance.

De Miguel A, Ibanez B, Badimón JJ.

Thromb Haemost. 2008 Aug;100(2):196-203. Review.

PMID:
18690337
[PubMed - indexed for MEDLINE]
16.

Antiplatelet drug 'resistance'. Part 1: mechanisms and clinical measurements.

Sweeny JM, Gorog DA, Fuster V.

Nat Rev Cardiol. 2009 Apr;6(4):273-82. doi: 10.1038/nrcardio.2009.10. Review.

PMID:
19352331
[PubMed - indexed for MEDLINE]
17.

Utility of 96-well plate aggregometry and measurement of thrombi adhesion to determine aspirin and clopidogrel effectiveness.

Armstrong PC, Dhanji AR, Truss NJ, Zain ZN, Tucker AT, Mitchell JA, Warner TD.

Thromb Haemost. 2009 Oct;102(4):772-8. doi: 10.1160/TH09-04-0215.

PMID:
19806265
[PubMed - indexed for MEDLINE]
18.

Evaluation of clopidogrel responsiveness after drug-eluting stent implantation.

Price MJ.

Minerva Cardioangiol. 2009 Oct;57(5):657-66.

PMID:
19838155
[PubMed - indexed for MEDLINE]
19.

Prevalence of unresponsiveness to aspirin and/or clopidogrel in patients with stable coronary heart disease.

Lordkipanidzé M, Diodati JG, Schampaert E, Palisaitis DA, Pharand C.

Am J Cardiol. 2009 Nov 1;104(9):1189-93. doi: 10.1016/j.amjcard.2009.06.025. Epub 2009 Sep 16.

PMID:
19840560
[PubMed - indexed for MEDLINE]
20.

Prevalence and risk factors for aspirin and clopidogrel resistance in patients with coronary artery disease or ischemic cerebrovascular disease.

Kim H, Lee HK, Han K, Jeon HK.

Ann Clin Lab Sci. 2009 Summer;39(3):289-94.

PMID:
19667414
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk